baSeq

𝐌𝐚𝐧𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐛𝐥𝐨𝐜𝐤𝐛𝐮𝐬𝐭𝐞𝐫 𝐝𝐫𝐮𝐠𝐬 𝐰𝐨𝐧’𝐭 𝐜𝐨𝐦𝐞 𝐟𝐫𝐨𝐦 𝐖𝐞𝐬𝐭𝐞𝐫𝐧 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 The rapid iteration and development of the Chinese biotech industry have become a goldmine churning out data and assets, and the West can’t keep up. Several $multi-billion deals have already happened between Western and Chinese companies, and the deal-flow is accelerating. The biggest bottleneck to access is the unstructured and incomplete data on the progress and biological background of these assets. You would have to establish a knowledge graph consolidating data-crumbs from:
 · Conference abstracts, · Western and Eastern clinical trial databases, · Poorly formatted websites, · Publications, · Patent databases etc. Time and time again we have encountered Western biopharma companies spending weeks on manually stitching data to evaluate a single asset That is why we’ve built baSeq Atlas, an agentic database layer running on continuous inference to autonomously update and correct. With this, you can access thousands of Chinese therapeutic assets using nothing but a prompt and integrate the outputs directly into your existing agentic workflows or simply extract the data for your internal assessments. We are testing early access right now for companies looking to source from Chinese assets.

The biopharma industry is changing rapidly. At baSeq, we have build knowledge databases that capture these changes and integrate seamlessly into agentic bioinformatics and drug discovery workflows. Ping us if you would like to learn more! Lasse Vedel Jørgensen 🚀

𝐖𝐞 𝐡𝐚𝐯𝐞 𝐬𝐩𝐞𝐧𝐭 𝐭𝐡𝐞 𝐩𝐚𝐬𝐭 𝐦𝐨𝐧𝐭𝐡𝐬 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠. More soon. For now, just a hint: orchestration is key.

As baSeq slowly winds down for the Christmas break, we want to take the time to thank everyone who have provided us with invaluable information and trust and all of the strong relations we have build across academia and industry during our inaugural year. We can't wait to see what 2026 has in store, and continue to build a strong product and accelerate drug development and fundamental research across academia and industry.

We had a blast presenting and exhibiting baSeq at Oxford Global's Cell 2025 conference. Thanks to all the participants who stopped by our booth and shared how they work with data and all the related headaches they are experiencing. One thing is clear: Bioinformatics is in need of better software. We look forward to continue the development of baSeq in close collaboration with researchers. If you want to hear more, follow the link in the comments.

baSeq will be exhibiting in the Startup Zone at Oxford Global's Cell 2025 Conference, taking place in London on 11–12 November 2025! At baSeq we address the bottlenecks in the analysis of complex biological data, such as scRNA-seq, bulk RNA-seq and other omics data. Our platform lets researchers explore their own omics data directly, reducing back-and-forth with bioinformaticians, deepening biological insight, enabling an instant start, and avoiding costly outsourcing. Come by our booth and try out our software and let's have a chat about how we can help you accelerate your research. We are very excited to meet you all! 📍 Startup Zone 📅 Cell 2025 | London | 11–12 November 2025 #Cell2025 #baSeq #omics #scRNA #Biotech NextGen Biomed by Oxford Global

This Tuesday, baSeq joined a great lineup at LifeScience Totaldag at Department of Biochemistry and Molecular Biology, University of Southern Denmark. We loved the conversations with curious students and fellow companies, thanks for great event and for inviting us. See you next year! #Biochemistry #LifeScience #MolecularBiology #Networking #BMB #SDU

baSeq has partnered with Amplexa Genetics A/S Through this collaboration, researchers can access an end-to-end pipeline, from bulk RNA-seq data generation at Amplexa to processing, analysis, and visualization in baSeq. The partnership aims to make bulk RNA-seq data handling more seamless and accessible for research groups, supporting a smoother path from raw data to biological insight. We are proud of being a part of the shared commitment to improve the infrastructure behind danish sequencing-based research with the strong team at Amplexa Genetics. #Sequencing #RNAseq #Bioinformatics

At baSeq, our goal is pretty simple: make modern bioinformatics available to everyone. An important step in single cell sequencing data analysis is batch integration. Until now, Harmony has been our go to method, but we have just added Scanorama to the platform, while scVI is coming within the next couple of weeks. This will give users a practical toolkit: Harmony for fast integration when batches have similar composition; Scanorama when overlap is partial and you want to avoid over-correction; and soon, scVI for non-linear effects and very large datasets. If you’ve seen one method work better than another in tricky cases (uneven overlap, strong perturbations, multi-omics, cross-species), we’d love to hear about your experiences. And if you want to try out the different integration methods on your own dataset, feel free to reach out.